Harvard Apparatus Regenerative Technology, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Harvard Apparatus Regenerative Technology, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Harvard Apparatus Regenerative Technology, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2024 was -$1.86M, a 15.3% decline year-over-year.
  • Harvard Apparatus Regenerative Technology, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2017 was -$11.9M, a 2.98% decline from 2016.
  • Harvard Apparatus Regenerative Technology, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2016 was -$11.6M, a 1.21% increase from 2015.
  • Harvard Apparatus Regenerative Technology, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2015 was -$11.7M, a 5.9% decline from 2014.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.86M -$247K -15.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$2.52M +$92K +3.52% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$2.03M +$939K +31.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q3 2023 -$1.62M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$2.61M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$2.97M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2017 -$11.9M -$1.23M +$2.11M +63.1% Oct 1, 2017 Dec 31, 2017 10-K/A 2018-04-03
Q3 2017 -$14M -$3.24M -$190K -6.22% Jul 1, 2017 Sep 30, 2017 10-Q 2017-12-15
Q2 2017 -$13.8M -$3.6M -$891K -32.9% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-14
Q1 2017 -$12.9M -$3.84M -$1.37M -55.4% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-11
Q4 2016 -$11.6M -$3.33M -$1.04M -45.5% Oct 1, 2016 Dec 31, 2016 10-K/A 2018-04-03
Q3 2016 -$10.5M -$3.05M -$761K -33.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-12-15
Q2 2016 -$9.77M -$2.71M +$1.79M +39.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$11.6M -$2.47M +$160K +6.08% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$11.7M -$2.29M +$550K +19.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$12.3M -$2.29M +$391K +14.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$12.7M -$4.5M -$1.97M -78% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$10.7M -$2.63M +$377K +12.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$11.1M -$2.84M -$193K -7.29% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$10.9M -$2.68M -$623K -30.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$10.2M -$2.53M -$438K -21% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$9.81M -$3.01M -$989K -49% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$8.82M -$2.65M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$2.06M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$2.09M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$2.02M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.